Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate for Hemodynamic Stability in Toxic Goiter Resection
NCT04632524Phase 4Completed
- Sponsor
- Fayoum University Hospital
- Start
- Oct 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of magnesium sulfate in Hyperfunctioning Multinodular Goiter (MNG), sponsored by Fayoum University Hospital. Started Oct 2020; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
Hyperfunctioning Multinodular Goiter (MNG)
Beyond the preview
Go deeper on NCT04632524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04632524.